Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Long-Term Investments (2022 - 2025)

Rallybio's Long-Term Investments history spans 4 years, with the latest figure at $626000.0 for Q2 2025.

  • On a quarterly basis, Long-Term Investments rose 10.21% to $626000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $626000.0, a 10.21% increase, with the full-year FY2023 number at $239000.0, up 696.67% from a year prior.
  • Long-Term Investments hit $626000.0 in Q2 2025 for Rallybio, up from $413000.0 in the prior quarter.
  • Over the last five years, Long-Term Investments for RLYB hit a ceiling of $626000.0 in Q2 2025 and a floor of $30000.0 in Q4 2022.
  • Historically, Long-Term Investments has averaged $325555.6 across 4 years, with a median of $304000.0 in 2024.
  • Biggest five-year swings in Long-Term Investments: soared 696.67% in 2023 and later rose 10.21% in 2025.
  • Tracing RLYB's Long-Term Investments over 4 years: stood at $30000.0 in 2022, then soared by 696.67% to $239000.0 in 2023, then skyrocketed by 80.33% to $431000.0 in 2024, then soared by 45.24% to $626000.0 in 2025.
  • Business Quant data shows Long-Term Investments for RLYB at $626000.0 in Q2 2025, $413000.0 in Q1 2025, and $431000.0 in Q3 2024.